Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 3Thoracic 2Lymphoid 2Other hematologic neoplasm 1Other 1Dermatologic 1CNS 1

Conditions

Smoking 1Pulmonary Disease, Chronic Obstructive 1Overweight 1Obesity 1Noncommunicable Diseases 1Neoplasms 1Hypokinesia 1Hypertension 1Hyperglycemia 1Dyslipidemias 1Diabetes Mellitus 1Coronary Disease 1Cerebrovascular Disorders 1Asthma 1Alcohol Drinking 1

Interventions

Surveys and Questionnaires 9Blood Specimen Collection 5naloxegol 3Therapeutics 3Observation 3Interviews as Topic 3Bariatric Surgery 3naldemedine 2exemestane 2Tirzepatide 2Tamoxifen 2Psychiatric Rehabilitation 2Paclitaxel 2Hematologic Tests 2Esophagectomy 2Echocardiography 2Carboplatin 2Biopsy 2BaseLine dental cement 2Anastrozole 2trametinib 1sotorasib 1semaglutide 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Electrocardiography × Other × Clear all
NCT06812767 2025-02-06

FORTUNE

National Medical Research Center for Therapy and Preventive Medicine

Enrolling by invitation
2,000 enrolled
Other

Noncommunicable Diseases, Alcohol Drinking, Asthma, Cerebrovascular Disorders, Coronary Disease, Diabetes Mellitus, Hyperglycemia, Hypertension, Neoplasms, Obesity, Smoking, Hypokinesia, Pulmonary Disease, Chronic Obstructive, Dyslipidemias, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡